Kelly Moran

Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein.

Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

Optimal management strategy for incidental findings in trauma patients: an initiative for midlevel providers.

Elevated carbon dioxide does not offset loss of soil carbon from a corn-soybean agroecosystem.

An initiative by midlevel providers to conduct tertiary surveys at a level I trauma center.

Chiral cationic polyamines for chiral microcapsules and siRNA delivery.